Format

Send to

Choose Destination
Curr Opin Pharmacol. 2019 Dec;49:24-28. doi: 10.1016/j.coph.2019.04.009. Epub 2019 May 11.

Fecal microbiota transplantation donation: the gift that keeps on giving.

Author information

1
Division of Gastroenterology & Hepatology, Department of Internal Medicine, St. Joseph's Hospital and Medical Center/Creighton University, Phoenix, AZ, USA.
2
Division of Gastroenterology & Hepatology, Department of Internal Medicine, University of Missouri-Columbia, Missouri, USA.
3
Division of Gastroenterology & Hepatology, Department of Internal Medicine, University of Missouri-Columbia, Missouri, USA. Electronic address: tahanv@health.missouri.edu.

Abstract

Fecal microbiota transplantation (FMT) is being studied and utilized for various medical conditions including Clostridium difficile colitis, inflammatory bowel diseases (IBD), obesity, myasthenia gravis, and so on. Yet, FMT donation, whether from an individual or a stool bank, can be challenging given the numerous requirements and donor costs. Furthermore, data outcomes on recipients of FMT regarding donor's health co-morbidities, age, and weight are limited but emerging. The purpose of this review is to evaluate cost, safety, and accessibility in FMT donation.

PMID:
31085417
DOI:
10.1016/j.coph.2019.04.009

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center